Company Overview of GMO Trust - GMO Benchmark-Free Allocation Fund
GMO Trust - GMO Benchmark-Free Allocation Fund is an open-ended balanced fund of funds launched and managed by Grantham, Mayo, Van Otterloo & Co. LLC. It invests in funds that invest in public equity and fixed income markets across the globe. The fund seeks to invest in funds that spread its investments across diversified sectors. It typically employs a combination of fundamental and quantitative analysis to create its portfolio. GMO Trust - GMO Benchmark-Free Allocation Fund was formed on July 23, 2003 and is domiciled in the United States.
40 Rowes Wharf
Boston, MA 02110-3340
Founded in 2003
Key Executives for GMO Trust - GMO Benchmark-Free Allocation Fund
Similar Private Companies By Industry
|@Visory LLC||United States|
|1 Road Partners LLC||United States|
|11T Partners, LLC||United States|
|123Jump.com, Inc.||United States|
|1509225 Ontario, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact GMO Trust - GMO Benchmark-Free Allocation Fund, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.